Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/08/2843114/0/en/Structure-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Highlights.html
https://www.reuters.com/business/healthcare-pharmaceuticals/structures-diabetes-pill-misses-weight-loss-expectations-mid-stage-trial-2023-12-18/
https://www.globenewswire.com//news-release/2023/11/14/2780528/0/en/Structure-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Highlights.html
https://www.fiercebiotech.com/biotech/structure-posts-early-oral-obesity-data-delays-larger-readout-after-data-collection-mistake
https://www.globenewswire.com//news-release/2023/09/29/2751920/0/en/Structure-Therapeutics-Announces-300-Million-Private-Placement-Equity-Financing.html
https://www.globenewswire.com/news-release/2023/08/10/2723141/0/en/Structure-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Recent-Highlights.html
https://www.globenewswire.com/news-release/2023/08/03/2718677/0/en/Structure-Therapeutics-Appoints-Ted-W-Love-M-D-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2023/06/07/2683760/0/en/Structure-Therapeutics-Announces-Poster-Presentations-of-its-Oral-GLP-1-Receptor-Agonist-GSBR-1290-at-the-American-Diabetes-Association-83rd-Scientific-Sessions.html
https://www.globenewswire.com/news-release/2023/05/31/2679822/0/en/Structure-Therapeutics-to-Present-at-Jefferies-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2023/05/25/2676736/0/en/Structure-Therapeutics-Initiates-Phase-2a-Study-of-Oral-GLP-1-agonist-GSBR-1290-for-the-Treatment-of-Type-2-Diabetes-and-Obesity.html